Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    RGX-202

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    REGENXBIO Completes Pivotal Enrollment, Duchenne Gene Therapy
    REGENXBIO Completes Pivotal Enrollment, Duchenne Gene Therapy

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-completion-of-pivotal-enrollment-and-initiates-commercial-production-in-duchenne-gene-therapy-program-302599520.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Regenxbio Announces Presentation At The World Muscle Society
    Regenxbio Announces Presentation At The World Muscle Society

    29 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-presentation-at-the-world-muscle-society-302569161.html

    PR NEWSWIRE
    29 Sep 2025
    Share Share
    Regenxbio Shows Benefits of Microdystrophin in Duchenne Gene
    Regenxbio Shows Benefits of Microdystrophin in Duchenne Gene

    11 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/regenxbio-announces-publication-of-preclinical-results-demonstrating-functional-benefits-of-novel-microdystrophin-construct-in-rgx-202-investigational-gene-therapy-for-duchenne-muscular-dystrophy-302502606.html

    PR NEWSWIRE
    11 Jul 2025
    Share Share
    Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid
    Inspirna Partners with Merck to Accelerate Global Development of Ompenaclid

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104830287/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid
    Inspirna Announces Clinical Data from Phase 1b/2 Study of Ompenaclid

    23 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231023708620/en

    BUSINESSWIRE
    23 Oct 2023
    Share Share
    Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid
    Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid

    16 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231016553717/en

    BUSINESSWIRE
    16 Oct 2023
    Share Share